A multicenter, double-blind, randomized comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with highly emetogenic chemotherapy. S3AA3012 Study Group.
Support Care Cancer
; 7(5): 347-53, 1999 Sep.
Article
en En
| MEDLINE
| ID: mdl-10483821
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Vómitos
/
Cisplatino
/
Ondansetrón
/
Antieméticos
/
Náusea
/
Neoplasias
/
Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
País como asunto:
Caribe
/
Mexico
/
Puerto rico
Idioma:
En
Año:
1999
Tipo del documento:
Article